Marketresearchnews

Tuesday, 27 October 2020

Global Clinical Nutrition Market is Expected to Experience Immense Growth During 2020 – 2027

Global Clinical Nutrition Industry research report offers granulated yet in-depth analysis of revenue share, market segments, revenue estimates and various regions across the globe.

Clinical Nutrition Market Highlights

Market Research Future reports say that the global clinical nutrition market would reach a higher valuation of its expected valuation by 2027. The predicted rate of growth for the market is mentioned to be substantial during the years from 2016 to 2027.

Also Read : https://www.medgadget.com/2020/02/clinical-nutrition-market-report-size-2020-global-industry-growth-research-study-development-pipeline-competitive-landscape-top-key-players-regional-revenue.html

Top Market’s Drivers & ChallengesThe study focuses on the fact that with the increasing aged population, the expenditure of clinical nutrition is estimated to rise in the future. Such a factor is framed to be an essential factor leading the market’s growth in the present years.

At the same time, due to the weak digestive framework at an old age, it becomes problematic for the human body to digest the required nutrients from food. Resulting from this, the loss of appetite is considered a significant issue due to which the elderly population does not get the necessary amount of nutrients. This is where clinical nutrition treatment is introduced. Such a factor has, therefore, become a key factor capitalizing the market of clinical nutrition treatment for the forecast period.

At present, clinical nutrition support is growing at a rapid pace. The global clinical nutrition market is going up with more factors such as high birth rate, a rise in the number of victims getting malnutrition treatment, and a high number of premature births. These have sored the use of clinical nutrition treatment and thus boosted its growth opportunities to the next level. All these factors have evolved as a vital factor causative to the growth of the market.

Furthermore, the study also reveals that the healthcare expenditure endures growing faster than economic growth in most of the countries, thus maintaining a trend observed over the decades. Therefore, as the healthcare expenditure increases in major countries of the world, the broader applicability of the treatment has provoked capitalized the market, which made it witness high growth in the forecast period.

Clinical Nutrition Market Segmentation

The analysis of the global clinical nutrition market has studied the segmental analysis, which included segments such as product types.

The product type segment thus includes infant nutrition—which further gets segmented among milk, soy, organic, others, and probiotic/prebiotic. The segment of enteral nutrition includes standard and for chronic illness as well as parenteral nutrition.

Clinical Nutrition Market Regional Outlook

The regional scrutiny of the global clinical nutrition market has been done over the key regions of North America, Europe, Asia– Pacific and The Middle East& Africa.

Among these regions, in 2014, North America held the position of the third-largest market for clinical nutrition products, by occupying 23.1% of the global market share. The U.S. leads the market in the North American region. The growth in consumer awareness about health and wellbeing, along with the swelling healthcare cost, is inspiring the demand for clinical nutrition products in the region. With this, the high birth rate is also one of the main drivers of the market in the region.

Asia-Pacific has the highest growth in the market, in comparison to the other regions. This is mainly due to high levels of malnutrition and the incidence of severe chronic diseases in the region. Thus, owing to the augmented metabolic disorders and rising income inequality in various countries, the region is also probable to by stand robust growth over the forecast period.

Clinical Nutrition Market Key Players

The prominent key players that are involved in the Global Clinical Nutrition market are Hospira, Nestlé S.A, Abbott Laboratories, B. Braun Melsungen AG, Fresenius Kabi AG, Baxter International, Inc, Mead Johnson Nutrition Company, GroupeDanone, Inc, Perrigo Company Plc and among others.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/global-clinical-nutrition-market-829

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Statistical Report, Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Market Research Future

Hadapsar, Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Bone Graft Substitutes Market: Information, Analytical Insights and growth of 2020 – 2027

An expert on premium research reports, Market Research Future has added a report titled “Global Bone Graft Substitutes Market 2027” to its offering. The report provides an in-depth analysis of regional data and an accurate projection of the market size and share of the Top 10 market players across the globe.

Market Research Future (MRFR)’s latest study reveals that the Global Bone Graft Substitutes Market is expected to expand at 6.52% CAGR during the forecast period 2017 to 2027.The market is set to reach a valuation of USD 5,031 Mn by the end of the assessment period. Bone Graft Substitute Market information: by type (autograft, demineralized bone matrix, synthetic bone grafts, bone morphogenetic protein, others), by application (spinal fusion, joint reconstruction, long bone, dental, foot & ankle, others) – Global forecast till 2027

Also Read : https://www.medgadget.com/2019/04/bone-graft-substitutes-market-2019-global-size-share-trends-competitive-analysis-growth-insights-by-2023.html

Key Players – Bone Graft Substitutes Market

Stryker Corporation,
ACE Surgical Supply Company, Inc.,
Dentium Co., Ltd.,
Dentsply Sirona,
Institut Straumann AG,
BioHorizons IPH, Inc.,
Medtronic plc, and
Zimmer Biomet.

Bone Graft Substitutes Market – Overview

As per Market Research Future (MRFR)’s latest analysis, the global bone graft substitutes market is estimated to strike a CAGR of 6.52% over the forecast period 2017 to 2027. Autografts have been used for years to treat bone disorders. It is one of the extensively used surgical procedures for bone grafting. However, the pain associated with the surgery has led to the innovation of alternatives such as allografts, xenografts, etc. This, in turn, is projected to catalyze the expansion of the bone graft substitutes market in the forthcoming years.

The rising geriatric population has catapulted the orthopedic industry on an upward trajectory. It is likely to fuel demand for bone graft substitutes over the assessment period. Additionally, the growing demand for bone grafts from the dental care industry is expected to boost the proliferation of the market across the next couple of years.

The factors that are responsible for dictating the growth trajectory of the bone graft substitutes market during the projection period are high demand in military medical units, increasing orthopedic problems, rising need for reconstructive orthopedic treatments, etc. However, there are certain restraints in the market, which include the risk of disease transmission in allografts and xenograft, improper fixation and weak bonding, and risk of graft rejection.

Industry News:

In March 2018, Dentsply Sirona, a dental solution company, announced the acquisition of over OraMetrix, a provider of innovative 3D technology solutions for orthodontic care. The acquisition is a remarkable step towards the advancement of dental bone graft procedure.

In August 2018, Scandinavian orthobiologics company Bone Support received approval from Health Canada for Cerament G bone graft substitute.

In September 2018, Baxter International Inc., an American healthcare company, announced the receipt of FDA clearance for Actifuse Flow bone graft substitute to be used in orthopedic surgical procedures.

In November 2018, Bio2 Technologies, an orthopedic company, has received approval from FDA for evaluation of its Vitrium bioactive glass as a cervical interbody fusion device. Vitrium is currently in use as a bone graft.

Segments – Bone Graft Substitutes Market

Based on type, the global bone graft substitutes market has been segmented into autograft, demineralized bone matrix, synthetic bone grafts, bone morphogenetic protein, and others.

Based on application, the bone graft substitutes market has been segmented into spinal fusion, joint reconstruction, long bone, dental, foot & ankle, and others.

Regional Analysis – Bone Graft Substitutes Market

The global bone graft substitutes market, by region, has been segmented into Americas, Europe, Asia Pacific, and the Middle East & Africa. Americas is the largest market for bone graft substitutes. The consolidation of major manufacturers in the region coupled with the swift uptake of novel technologies is likely to drive the growth of the bone graft substitutes market in the region. The U.S. is a significant country-level market of the region and is expected to contribute largely towards the development of the regional bone graft substitutes market in the forthcoming years.

Europe held the second-largest share of the global market and is poised to retain its potential through the assessment period. The factors that are contributing towards the growth of the market in Europe include rising awareness about bone graft substitutes, increasing healthcare expenditure, availability of funds for research & development, etc.

Asia Pacific is the fastest growing bone graft substitutes market and has been estimated to mark a CAGR of 6.85% during the forecast period. The developments in the fast-developing country-level markets such as India and China are inducing growth in the regional market. It is expected to exhibit a similar trend throughout the projection period.

The Middle East & Africa is set to witness steady growth over the next couple of years. Gulf nations, particularly, Saudi Arabia and the U.A.E. are primarily responsible for driving the growth of the bone graft substitutes market in the region.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/bone-graft-substitutes-market-1195

About Market Research Future:

Market Research Future

Hadapsar, Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Apheresis Market | Worldwide Top key Players Profile Analysis | Forecast till 2023

Recently MRFR, a leading market research firm collated a novel report on “Global Apheresis Market Research Study” that gives comprehensive market overview about the current market dynamics with a focus on the worldwide market.

The Global Apheresis Market is presumed to register 10.2 % CAGR during the forecast period (2017-2023), owing to the increasing prevalence of chronic renal diseases, asserts Market Research Future (MRFR).

Apheresis is referred to as the procedure of separating and purifying the blood for treating several renal, neurological, autoimmune, hematological, and other diseases. Apheresis involves removal of the blood from the donor or patients and collecting it into an apparatus which separates the component from the blood. The rest of the blood is sent to the patients or the donors. The separation is mainly done using filtration and centrifugation.

Also Read : https://www.medgadget.com/2019/01/global-apheresis-market-expected-to-reach-10-2-till-2023-global-analysis-of-product-procedure-growth-trends-industry-insights-demand-and-forecast.html

With the growing prevalence of chronic renal diseases and blood-related diseases, the global apheresis market is considered to stimulate during the estimated period. Increasing complex surgical procedures, rising demand for different component of blood, and growing number of accidents across the globe are considered to augment the market growth in the coming years. Demand for platelets and plasma has also increased which is further impacting the global market positively. Moreover, with continuous advancement in technology and growing need for advanced and automated devices, the market is likely to foster.On the flip side, high cost of procedures and lack of skilled professionals are some of the major factors considered to impede the market growth in the coming years.

Key Players:

Market Research Future (MRFR) recognizes the following companies as the key players in Apheresis Market: There are plenty of large and small market players which operate in this market all over the globe.

The major players operating the global market are Kaneka Corporation (Japan), Terumo BCT Inc. (US), Fresenius Medical Care (Germany), Nikkiso Co. Ltd. (Japan), Asahi Kasei Medical Co. Ltd. (Japan), B. Braun Melsungen AG (Germany), Nikkiso Ltd. (Japan), HemaCare Corporation (US), Cerus Corporation (US), Haemonetics Corporation (US), Kawasumi Laboratories Inc. (Japan), Therakos, Inc. (U.S.), and others.

Industry Updates:

January 2018: MedAware Systems Inc. has recently launched a comprehensive database on apheresis through its SOHInfo division, carrying data from clinical trials, medical journals, cohort studies, and others.

Segments:

The Global Apheresis Market has been segmented on the basis of product, procedure, methods, application, end-users, and region.

By mode of product, global apheresis market has been segmented into devices and disposables. The devices segment has been further sub-segmented into platelets separators, plasma separators, and others.

By mode of procedure, the global apheresis market has been segmented into leukapheresis, plateletpheresis, plasmapheresis, erythrocytapheresis, and others.

By mode of methods, the global apheresis market has been segmented into filtration and centrifugation. Among these, centrifugation is further sub-segmented into intermittent flow centrifugation, continuous flow centrifugation, and others.

By mode of application, the global apheresis market has been segmented into oncological diseases, immunological diseases, hematological diseases, cardiovascular diseases, renal diseases, neurological diseases, and others.

By mode of end-users, the global apheresis market has been segmented into hospitals, blood banks, and others.

Regional Analysis:

Geographically, Apheresis Market span across regions namely, America, Europe, Asia Pacific, and Rest-of-the-World (RoW).

Among all the regions, America is considered to hold the largest position in the global market and is expected to maintain its dominance during the assessment period. The growth is attributed to the advancement in technology and growing opportunity for apheresis products coupled with the presence of a huge patient population suffering from chronic diseases.

Asia Pacific is considered to be the fastest growing region in the global market owing to the growing demand for blood components for patients. Moreover, rapid development in the healthcare industry along with growing expenditure on health care is considered to contribute to the growth of the global market.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/apheresis-market-1508

About Market Research Future:

Market Research Future

Hadapsar, Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Hospital Furniture Market | Worldwide Top key Players Profile Analysis | Forecast till 2023

Hospital FurnitureMarket report by MRFR contains all analytical and statistical transient regarding Market summary, Growth, Demand and Forecast analysis with penetrating summary and solution within the complex industry.

Hospital Furniture Market is expected to reach at 9.8% CAGR during forecast period from 2019 to 2023, by research report from Market Research Future (MRFR). The global hospital furniture market is mainly driven by the growing demand from emerging economies to develop their healthcare sector and the increasing investment in the healthcare sector by private entities, leading to a growing demand for premium, expensive hospital furniture offering the latest in ergonomics and comfort. Growing Demand in India, China to Drive Hospital Furniture Market.

Also Read : https://www.medgadget.com/2019/10/hospital-furniture-market-growth-insight-trends-size-2019-global-share-new-development-key-country-analysis-and-forecast-to-2023.html

Hospital Furniture Market Competitive AnalysisLeading players in the global hospital furniture market include

Beaver Healthcare Equipment,
Moore Medical LLC,
Renray Healthcare Ltd.,
Bristol Maid Hospital Metalcraft,
DRE Inc.,
Anetic Aid Limited,
KI,
Bio Medical Solutions,
Narang Medical,
Hill-Rom,
Chang Gung Medical Technology,
GPC Medical Ltd.,
The Brewer Company,
Stryker Corporation

In September 2019, a new super-specialty ward is expected to open in the Government Medical College and Hospital in Aurangabad, India. Redevelopment of existing medical facilities is likely to pick up speed in India in the coming years, making it a leading regional market for hospital furniture and driving the global hospital furniture market over the forecast period.

Segments – Hospital Furniture Market

The global hospital furniture market is segmented on the basis of type into bedside tables, OT table, instrument stands, stretchers, hospital beds, chairs, scrub sinks, waste container, trolley and others.

On the basis of application, the global hospital furniture market is segmented into physician furniture, patient’s furniture, and staff’s furniture. Physician furniture is sub-segmented into examination table, surgery chair, and others. Patient furniture is sub-segmented into stretchers, bedside table, and other, while staff’s furniture is further segmented into stands and others.

On the basis of end users, the market is segmented into hospital, diagnostic centres, clinics and others. Hospitals hold the dominant share in the global hospital furniture market of 65% and are likely to remain the leading revenue generator in the global hospital furniture market over the forecast period.

Regional Analysis – Hospital Furniture Market

The Americas is likely to be the major revenue generator in the global hospital furniture market over the forecast period due to the growing demand for advanced hospital furniture in North America, especially the U.S. The growing presence of the private healthcare sector in North America is likely to be a major driver for the hospital furniture market in the Americas region over the forecast period. Private healthcare entities make more of an effort to pick the best furniture, to woo patients and new customers, whereas state-sponsored healthcare initiatives mainly pick hospital furniture based on utility rather than design or fashion. Thus, the strong presence of the private healthcare sector in North America is likely to be a major driver for the global hospital furniture market over the forecast period.

Europe is the second largest regional market for hospital furniture and is likely to hold on to a significant share in the global hospital furniture market over the forecast period. Europe is also home to several leading players in the healthcare sector, leading to a growing preference for expensive hospital furniture of a higher quality. The increasing efforts taken by the healthcare sector to engage and interact with patients in Europe are likely to be a key driver for the hospital furniture market in the region over the forecast period.

Asia Pacific is the third largest regional market for hospital furniture, and is expected to exhibit the fastest growth over the forecast period due to the growing demand from the increasingly well-funded healthcare sector in the region. The healthcare sector in developing APAC economies such as India and China has exhibited robust progress in the last few years due to the increasing government support and the increasing investment from private sector individuals. This is likely to result in an increasing demand for hospital furniture in the region over the forecast period, as several new hospitals are likely to be constructed in this region over the forecast period, as well as renovation and redevelopment efforts bearing fruit.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/hospital-furniture-market-1007

About Market Research Future:

Market Research Future

Hadapsar, Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Future Scope of Blood Glucose Test Strip Market is Witness to Grow High CAGR till 2023

Blood Glucose Test Strip Market report focuses on the key player’s profiles in detail with granular analysis of the market share, production technology, market entry strategies, revenue forecasts and regional analysis of the market.

The global blood glucose test strips market is growing rapidly mainly due to the growing number of in diabetic patients, worldwide. Moreover, significant investments transpired into R&D to bring about improvements in the existing product line as well to develop new effective strips are escalating the market on the global height.

Acknowledging the continually ascending graph of the market growth, Market Research Future (MRFR) in its recently published study report asserts that the global blood glucose test strips market will garner the worth of USD 18.5 BN by 2020, growing at a CAGR over 6.2% throughout the review period (2015 – 2020).

Also Read :https://www.medgadget.com/2019/04/blood-glucose-test-strip-market-2019-opportunities-cagr-status-drivers-business-growth-and-forecast-to-2023.html

Drivers and Constraints Impacting the Market

Blood glucose test strips are self-testing strips which let pre-diabetic and diabetic people track their blood glucose level on a regular basis without visiting a diagnostic laboratory or a clinic. With the growing diabetic population, the global market for blood glucose test strip is considered to foster during the assessment period. For instance, as per the International Diabetic Federation, around 415 million people had diabetes in 2015. The number is estimated to reach 642 million by the end of 2040. Moreover, technological advancements such as accuracy of the tests along with awareness among the people regarding diabetes are stimulating the market growth.

On the flip side, product recall owing to the inefficiency of devices such as intense competition resulting in pricing pressure and false glucose reading are some of the major factors considered to impede the global blood glucose test strip market in the coming years.

Global Blood Glucose Test Strip Market: Segmental Analysis

The Blood Glucose Test Strip Market has been segmented on the basis of technology, distribution channel, and region.

By mode of technology, the global blood glucose test strip market has been segmented into optical, thin film electrochemical, and thick film electrochemical.

By mode of distribution channel, the global blood glucose test strip market has been segmented into retail pharmacy and hospital pharmacy. Among these, the hospital pharmacy is likely to dominate the global market and is anticipated to maintain its dominance over the assessment period. The growth is attributed to the increasing preference for self-care testing among the patients to monitor diabetes.

Regional Insights

Geographically, the global blood glucose test strip market span across regions namely, North America, Europe, Asia Pacific, and the Middle East and Africa.

Among all the regions, North America is presumed to lead the global blood glucose test strip market with $ 7.89 billion revenue. The growth is attributed to the extensive use of information technology coupled with high expenditure on healthcare. Moreover, the presence of major medical device manufacturers and high adoption of latest technologies are considered to stimulate the market during the review period.

Europe is estimated to hold the second position in the global market and is likely to maintain its dominance during the review period. High healthcare expenditure led by France and Germany is anticipated to drive the global market.

The Asia Pacific region is presumed to expand at a rapid pace owing to the presence of major regions such as India and China which are expected to lead the market due to unmet needs. This region is presumed to expand at 12.9 % CAGR owing to the growing number of diabetic population.

Industry Updates

January 2018: Ascensia Diabetes Care has recently announced the expansion of its strategic alliance with the Insulet Corporation which is a leader in tubeless insulin pump technology. The expansion follows the worldwide non-exclusive development agreement that Ascensia had announced in June 2017, to connect its CONTOUR NEXT ONE blood glucose monitoring system with Insulet’s next-generation Omnipod System.

Competitive Dashboard

The major players operating the global market are Apex Biotechnology Corp, Shanghai MicroSense, ALL Medicus, Beijing Yicheng Electronics, Elektronika, Nipro Diagnostics, Bayer Diabetes Care, B. Braun, LifeScan, ACON Laboratories, Jiangsu Yuyue, HMD BioMedical Inc., TaiDoc, Betachek National Diagnostics, Roche Diagnostics, i-SENS, Universal Biosensors, Abbott, SANNUO, AgaMatrix Inc, and others.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/global-blood-glucose-test-strip-market-976

About Market Research Future:

Contact Us:

Market Research Future

Hadapsar, Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Human Growth Hormone Market is Growing Massively till 2023

This study covers the market dynamics and trends in major countries that are expected to influence the current market scenario and future status of the Global Human Growth Hormone Market over the forecast period.

The report titled as “Human Growth Hormones Market” Research Report implements an exhaustive study on MarketResearchFuture.com and This Report Cover market size, growth rate, market Dynamics and Factor Analysis. And also cover the other information such as Human Growth Hormones Market trends, Top players and Forecast till 2023.

Segments for Global Human Growth Hormones Market

The global human growth hormone market has been segmented on the basis of brand, application, route of administration, distribution channel, and region.Also Read :https://www.medgadget.com/2019/09/human-growth-hormone-market-size-share-2019-global-analysis-by-growth-trends-drugs-key-players-region-with-global-industry-forecast-to-2023.html

The market, based on brand, has been segmented into Genotropin, Humatrope, Norditropin, Omnitrope, Sainzen, and others. Among these, the Norditropin segment has been expected to account for the largest market share and is projected to record the highest CAGR of 11.81% during the assessment period

Based on the application, the market has been segmented into growth hormone deficiency, idiopathic short stature, Prader-Willi syndrome, small for gestational age, Turner syndrome, and others. The growth hormone deficiency segment has been assessed as the largest segment in terms of market value and is anticipated to grow at the highest CAGR of 7.07% during the forecast period.

On the basis of the route of administration, the market has been segmented into intramuscular, intravenous, subcutaneous, and oral. The subcutaneous segment has been assessed to record the highest market share the highest CAGR among the route of administration segment, and account for 39% of the market share during the forecast period.

Based on the distribution channel, the human growth hormone market has been segmented into clinics, e-commerce websites, hospital pharmacies, and retail pharmacies. The hospital pharmacies segment has been assessed to reach a valuation of USD 2,473.21 million, growing at the highest CAGR in this segment over the forecast period.

Based on the region, the global human growth hormone market has been segmented into the Americas, Europe, Asia Pacific (APAC), and the Middle East & Africa (MEA).

Market Drivers

Market Research Future (MRFR’s) latest study reveals that the global market for human growth hormone will surge at an impressive CAGR of 7.50% during the review period (2018-2023). Growth hormone deficiency falls under the list of endocrine conditions. Growth hormone deficiency is prevalent across the globe and the reasons for the condition usually vary from person to person. Though the condition is rare, its prevalence rate has increased to a noteworthy level in recent times. In many cases, brain injury has been identified as a primary cause of growth hormones deficiency. Low level of growth hormone secretion can lead to altered body composition, osteoporosis, insulin resistance, lipid abnormalities, reduced energy levels, and reduced muscle strength. Low growth hormone secretion is usually an issue that starts at a young age and if not addressed promptly, may have major implications in later stages of life.

The human growth hormone (HGH) is an essential part of bodily functions and is one of the most important hormones produced by the pituitary gland in the human body and is responsible for the growth in infants and adults as well. The deficiency of the human growth hormone in the body can create severe repercussions, and in order to avoid the risks, medical professionals have now developed synthetically produced and administered human growth hormone.

Technological advancements in the healthcare sector along with rising investment in research and development, increasing awareness related to hormone therapy, and the growing prevalence of growth hormone deficiency are the factors influencing the growth of the global market for human growth hormone.

Competitive Analysis:

The players in the global human growth hormones market are aiming towards business expansion by increasing the research and development expenditure for introducing highly effective products in the global market. Increasing focus on strategic mergers and acquisitions is aiding the players in sustaining the competitive environment of the global human growth hormones market.

The key players identified in the global market for human growth hormone are Anhui Anke Biotechnology Co. Ltd., BioPartners GmbH, Eli Lilly and Company, Ipsen S.A., GeneScience Pharmaceuticals Co. Ltd., Genetech Inc., Lifetech Labs, Merck KGaA, Novo Nordisk A/S, Novartis AG, Pfizer Inc, and Zhongshan Hygene Biopharm Co. Ltd.

Regional Analysis for Global Human Growth Hormones Market

The Americas have been accounted for around 50% of the global human growth hormone market owing to the growing prevalence of the deficiency of the growth hormone, and Turner syndrome in the region. North America has been assessed to dominate the market share over the forecast period, due to the presence of advanced economies such as the U.S. and Canada, with established healthcare sectors and affordable hormonal therapy.

Europe is the second largest regional human growth hormone market, owing to the presence of significant market players, and favorable government initiatives towards superior healthcare facilities for the consumers.

The Asia Pacific is the fastest rising region in the global human growth hormone market and has been assessed to grow exponentially at a CAGR of 7.70% over the forecast period, owing to influential factors such as the increase in expenditure by the government towards healthcare sector to provide consumers with proper medical facilities. Additionally, international market players have expressed keen interest in contributing to the growing development in the Asia Pacific region by investing in the potential markets for various domains, including the regional market for human growth hormone.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/human-growth-hormone-market-6494

About Market Research Future:

Market Research Future

Hadapsar, Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Detail Study on Biologics Safety Testing Market is Projected to Grow Magnificent CAGR till 2023

Market Research Future with their unique quality of simplifying the market research study, announces a deep study report on “Biologics Safety Testing Market Research Report – Forecast to 2023” Gives industry size, top players and worldwide demand

Biologics Safety Testing Market Analysis

Global biologics safety testing market is predicted to expand at a 13.6% CAGR between 2018-2023, reveals the new Market Research Future (MRFR) report. Biological safety testing is conducted to ensure both the non-contamination and safety of biopharmaceuticals and vaccines and also comply with its regulations. Bioburden tests, adventitious agent detection tests, residual host contamination detection tests, cell line authentication & characterization tests, endotoxin tests, sterility tests, and others are some major biological tests. It is used in stem cell research, tissue & tissue-related products testing, cellular & gene therapy, blood & blood-related products testing, and vaccine & therapeutics development.

Also Read : https://www.medgadget.com/2020/03/biologics-safety-testing-market-to-grow-at-13-6-cagr-by-2023-americas-to-command-largest-share-in-biologics-safety-testing-industry.html

Numerous factors are adding to theglobal biologics safety testing market growth. Such factors, as revealed by the recent MRFR report, include growing demand for biological products, growing biotech and pharmaceutical industry, rising number of innovative drug launches, and high prevalence and huge economic burden of various chronic diseases. Increasing research and development investment in life science and favorable government support are also adding market growth.On the contrary, high investment costs related to biological safety cabinets, time-consuming approval process, stringent government regulations, and scarcity of skilled professionals to conduct biological safety testing are factors that may limit the biologics safety testing market growth during the forecast period.

Biologics Safety Testing Market Key Players

Leading players profiled in the global biologics safety testing market report include

Eurofins Scientific
Avance Biosciences Inc.
Cytovance Biologics Inc.
Wuxi Apptec
Thermo Fisher Scientific Inc
SGS S.A.
Lonza Group Ltd.
Sartorius AG
Charles River Laboratories
Merck KGaA

Biologics Safety Testing Market Segmentation

The Market Research Future Report provides an inclusive segmental analysis of the biologics safety testing market based on application, test type, and product.

By product, the biologics safety testing market is segmented into instruments, services, and kits & reagents. Of these, kits and reagents will lead the market over the forecast period.

By test type, the biologics safety testing market is segmented into bioburden tests, adventitious agent detection tests, residual host contamination detection tests, cell line authentication & characterization tests, endotoxin tests, sterility tests, and others. Of these, endotoxin tests will dominate the market over the forecast period for increasing drug launches and rising disease prevalence. This testing is used in drug development, gene therapy, vaccine testing, monoclonal antibody testing, and cell therapy.

By application, the biologics safety testing market has been segmented into stem cell research, tissue & tissue-related products testing, cellular & gene therapy, blood & blood-related products testing, and vaccine & therapeutics development. Of these, vaccine & therapeutics development will have a major share in the market over the forecast period for rising company investments to develop vaccines, growing initiatives for immunization, and increasing prevalence of diseases.

Biologics Safety Testing Market Regional Analysis

By region, the biologics safety testing market covers the growth opportunities and recent trends across Europe, the Americas, the Middle East & Africa (MEA), and the Asia Pacific (APAC). Of these, the Americas will command the largest share in the market over the forecast period. Factors adding to the biologics safety testing market growth in the region include growing demand for biological products, new product launches, presence of well-established players, and growing pharmaceutical and biotechnology industries. Additional factors adding market growth include favorable government initiatives, rising R&D spending, and advanced healthcare infrastructure.

The global biologics safety testing market in Europe is predicted to hold the second-largest share during the forecast period for the growing biotech and pharma industry.

The biologics safety testing market in the APAC region is predicted to grow at a quick pace during the forecast period for the burgeoning demand for biologics products.

The biologics safety testing market in the MEA will have a small share over the forecast period. The Middle East will have major share for the presence of a well-established healthcare sector.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/biologics-safety-testing-market-6800

About Market Research Future:

Market Research Future

Hadapsar, Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com